Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Zhejiang Runtu Co., Ltd. (002440.SZ)
Shangyu, CN
Established in 1986 and headquartered in Shangyu, China, Zhejiang Runtu Co., Ltd. specializes in the production and distribution of dyes. The company boasts an extensive catalog of approximately 300 distinct chemical products, categorized across dyes, pigments, and additives. Its comprehensive range of dye products includes disperse, reactive, direct, blend, cationic, and vat varieties. Beyond its core dye offerings, Zhejiang Runtu also manufactures critical chemical intermediate products, textile auxiliaries, and industrial chemicals such as sulfuric acid, chlor-alkali, and hydrogen peroxide. While maintaining a strong presence within the Chinese market, the company extends its sales globally, exporting its goods to various international regions including Southeast Asia, the Middle East, Europe, and the United States.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.29% | -4.44% | -15.67% | -30.90% | +33.29% | +38.29% | +39.78% | +46.73% | +4.03% | +7.49% | +36.10% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-01 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+0.6% Q1'26: +31.6% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+221.1% ★ Q1'26: +300.0% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+9.5% ★ Q1'26: 0.0% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+8.1% Q1'26: +13.2% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+4.3% Q1'26: +8.0% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-2.3% ★ Q1'26: -3.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.27× ★ Q1'26: 0.14× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
4.52B
est: 4.44B (+1.9%)
|
4.35B
est: 4.32B (+0.7%)
|
6.06B
est: 5.61B (+7.9%)
|
6.46B
est: 6.97B (-7.3%)
|
6.51B
est: 6.88B (-5.3%)
|
5.23B
est: 6.08B (-14.0%)
|
5.57B
est: 7.54B (-26.1%)
|
6.27B
est: 5.57B (+12.5%)
|
5.59B
est: 6.06B (-7.8%)
|
5.70B
est: 5.61B (+1.5%)
|
5.73B
est: 5.75B (-0.4%)
|
7.13B
7.13B – 7.13B
+24.0% YoY
|
7.27B
7.27B – 7.27B
+2.0% YoY
|
| EBITDA |
1.07B
est: 694.56M (+54.4%)
|
1.08B
est: 676.61M (+59.4%)
|
1.50B
est: 878.91M (+70.6%)
|
1.87B
est: 1.09B (+71.1%)
|
1.72B
est: 1.08B (+59.5%)
|
1.05B
est: 951.94M (+9.9%)
|
1.09B
est: 1.18B (-7.6%)
|
895.20M
est: 872.81M (+2.6%)
|
585.29M
est: 949.15M (-38.3%)
|
794.88M
est: 820.85M (-3.2%)
|
852.24M
est: 841.46M (+1.3%)
|
1.04B
1.04B – 1.04B
+24.0% YoY
|
1.06B
1.06B – 1.06B
+2.0% YoY
|
| EBIT |
823.71M
est: 334.49M (+146.3%)
|
792.03M
est: 325.85M (+143.1%)
|
1.17B
est: 423.27M (+177.3%)
|
1.52B
est: 525.68M (+189.5%)
|
1.32B
est: 518.85M (+154.8%)
|
605.06M
est: 458.44M (+32.0%)
|
647.12M
est: 568.61M (+13.8%)
|
436.95M
est: 420.34M (+4.0%)
|
99.83M
est: 457.10M (-78.2%)
|
328.12M
est: 383.78M (-14.5%)
|
462.56M
est: 393.41M (+17.6%)
|
487.96M
487.96M – 487.96M
+24.0% YoY
|
497.54M
497.54M – 497.54M
+2.0% YoY
|
| Net Income |
733.78M
est: 973.81M (-24.6%)
|
660.10M
est: 666.68M (-1.0%)
|
934.85M
est: 910.13M (+2.7%)
|
1.31B
est: 1.28B (+2.7%)
|
1.37B
est: 1.39B (-1.1%)
|
788.18M
est: 1.02B (-22.5%)
|
835.62M
est: 1.54B (-45.7%)
|
606.51M
est: 651.70M (-6.9%)
|
45.77M
est: 415.74M (-89.0%)
|
213.49M
est: 230.44M (-7.4%)
|
669.36M
est: 406.01M (+64.9%)
|
735.20M
735.20M – 735.20M
+81.1% YoY
|
877.85M
877.85M – 877.85M
+19.4% YoY
|
| SGA |
530.40M
est: 364.84M (+45.4%)
|
563.77M
est: 355.41M (+58.6%)
|
465.34M
est: 461.68M (+0.8%)
|
627.64M
est: 573.38M (+9.5%)
|
641.45M
est: 565.93M (+13.3%)
|
531.06M
est: 500.04M (+6.2%)
|
505.79M
est: 620.20M (-18.4%)
|
488.37M
est: 458.48M (+6.5%)
|
453.59M
est: 498.58M (-9.0%)
|
340.77M
est: 417.18M (-18.3%)
|
356.03M
est: 427.66M (-16.7%)
|
530.44M
530.44M – 530.44M
+24.0% YoY
|
540.85M
540.85M – 540.85M
+2.0% YoY
|
| EPS |
0.64
est: 0.87 (-26.2%)
|
0.57
est: 0.59 (-3.4%)
|
0.81
est: 0.81 (+0.0%)
|
1.14
est: 1.14 (+0.2%)
|
1.19
est: 1.23 (-3.5%)
|
0.69
est: 0.91 (-23.8%)
|
0.74
est: 1.37 (-46.0%)
|
0.54
est: 0.58 (-6.9%)
|
0.04
est: 0.37 (-89.2%)
|
0.19
est: 0.21 (-9.5%)
|
0.61
est: 0.37 (+64.9%)
|
0.67
0.67 – 0.67
+81.1% YoY
|
0.80
0.80 – 0.80
+19.4% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-08 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-07 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-06 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-04-30 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-29 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-28 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-27 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - Emerging Markets Value ETF DFEV | 0.00% | 73.3K | 0.46% |
| 2 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 293.2K | 0.39% |
| 3 | Dimensional Emerging Markets Sustainability Core 1 ETF DFSE | 0.00% | 13.9K | 0.44% |
| 4 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 147.6K | 0.29% |
| 5 | Vanguard FTSE Emerging Markets UCITS ETF (USD) Distributing VDEM.L | 0.00% | 61.3K | 0.17% |
| 6 | Vanguard FTSE Emerging Markets UCITS ETF (USD) Accumulating VFEA.L | 0.00% | 61.3K | 0.17% |
| 7 | Invesco FTSE All-World UCITS ETF FWRA.SW | 0.00% | 45.9K | 0.15% |
| 8 | Invesco FTSE All-World UCITS ETF FTWG.L | 0.00% | 45.8K | 0.15% |
| 9 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 114.5K | 0.28% |
| 10 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 30.0K | 0.26% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Bo Ping Liu | Deputy GM & Secretary | — | male |
| Cheng Yu Zhou | Chief Financial Officer | — | male |
| Guang Dong Ruan | Deputy GM & Director | — | male |
| Heng Ru | Vice Chairman & Deputy GM | — | male |
| Jiewen Zhou | GM & Director | — | male |
| Xing Juan Ding | Accounting Supervisor | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 002440.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
